The Goldman Sachs Group, Inc. (<a rel="nofollow" class="qLink" href="#" OnClick="singleQuoteDialog('GS'); return false;">GS</a>) 13D/13G Filings for Seaport Therapeutics, Inc. Common Stock (<a rel="nofollow" class="qLink" href="#" OnClick="singleQuoteDialog('SPTX'); return false;">SPTX</a>)

The Goldman Sachs Group, Inc. 13D and 13G filings for Seaport Therapeutics, Inc. Common Stock:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Shares have been adjusted for stock splits.

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2026-05-11 3:19 pm Purchase	2026-05-06	13G	SEAPORT THERAPEUTICS INC SPTX	GOLDMAN SACHS GROUP INC GS	2,791,814 5.500%	2,791,814 (New Position)	Filing

The Goldman Sachs Group, Inc. (GS) 13D/13G Filings for Seaport Therapeutics, Inc. Common Stock (SPTX)